Catalyst Wire Dossier Catalyst Wire Dossier

Eltrekibart

LY3041658 · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Eltrekibart, covering 2025-10-16 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Eltrekibart (LY3041658) in Healthy Participants [Phase 1]

See pricing